2161 — Jbm (Healthcare) Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual income statement for Jbm (Healthcare), fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	406	520	648	782	835
Cost of Revenue
Gross Profit	162	206	338	414	466
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	367	433	474	536	571
Operating Profit	38.9	87	174	246	264
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	30.7	76.9	165	242	252
Provision for Income Taxes
Net Income After Taxes	23.3	63.3	137	203	210
Minority Interest
Net Income Before Extraordinary Items
Net Income	24.6	57.1	130	197	201
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	24.6	57.1	130	197	201
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.03	0.051	0.143	0.24	0.247
Dividends per Share